Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care

Abstract Background The safety of restarting angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) after acute kidney injury (AKI) is unclear. There is concern that previous users do not restart ACEI/ARB despite ongoing indications. We sought to determine the risk...

Full description

Bibliographic Details
Main Authors: Patrick Bidulka, Edouard L. Fu, Clémence Leyrat, Fotini Kalogirou, Katherine S. L. McAllister, Edward J. Kingdon, Kathryn E. Mansfield, Masao Iwagami, Liam Smeeth, Catherine M. Clase, Krishnan Bhaskaran, Merel van Diepen, Juan-Jesus Carrero, Dorothea Nitsch, Laurie A. Tomlinson
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Medicine
Subjects:
Acute kidney injury
Heart failure
Angiotensin-converting enzyme inhibitor (ACEI)
Angiotensin II receptor blocker (ARB)
Online Access:http://link.springer.com/article/10.1186/s12916-020-01659-x

Internet

http://link.springer.com/article/10.1186/s12916-020-01659-x

Similar Items